Literature DB >> 31313059

Central nervous system neuroblastoma metastases pseudoprogression following intraventricular anti-B7-H3 radioimmunotherapy.

Kim Kramer1, Osman Khan2, Sofia Haque3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31313059      PMCID： PMC7594109          DOI： 10.1007/s11060-019-03203-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  3 in total

1.  B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.

Authors:  Kimio Yonesaka; Koji Haratani; Shiki Takamura; Hitomi Sakai; Ryoji Kato; Naoki Takegawa; Takayuki Takahama; Kaoru Tanaka; Hidetoshi Hayashi; Masayuki Takeda; Sigeki Kato; Osamu Maenishi; Kazuko Sakai; Yasutaka Chiba; Takafumi Okabe; Keita Kudo; Yoshikazu Hasegawa; Hiroyasu Kaneda; Michiko Yamato; Kenji Hirotani; Masaaki Miyazawa; Kazuto Nishio; Kazuhiko Nakagawa
Journal:  Clin Cancer Res       Date:  2018-03-12       Impact factor: 12.531

Review 2.  B7-H3 in Cancer - Beyond Immune Regulation.

Authors:  Karine Flem-Karlsen; Øystein Fodstad; Ming Tan; Caroline E Nunes-Xavier
Journal:  Trends Cancer       Date:  2018-04-20

3.  B7-H3 promotes metastasis, proliferation, and epithelial-mesenchymal transition in lung adenocarcinoma.

Authors:  Ting-Ting Yu; Tao Zhang; Xi Lu; Ruo-Zheng Wang
Journal:  Onco Targets Ther       Date:  2018-08-10       Impact factor: 4.147
  3 in total
  1 in total

Review 1.  Strategies to Improve Chimeric Antigen Receptor Therapies for Neuroblastoma.

Authors:  Piamsiri Sawaisorn; Korakot Atjanasuppat; Usanarat Anurathapan; Somchai Chutipongtanate; Suradej Hongeng
Journal:  Vaccines (Basel)       Date:  2020-12-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.